Stay updated on ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:13:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a 403 Forbidden error page state with basic HTML boilerplate, indicating access is blocked; the surrounding site chrome remains visible, meaning this is an access issue rather than a content update.
    Difference
    17%
    Check dated 2026-09-20T20:16:27.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a new revision tag indicating a minor update to the page version. No changes to the study details or eligibility criteria are evident from this update.
    Difference
    0.1%
    Check dated 2026-08-30T21:43:38.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Results status updated from 'No Results Posted' to 'Results Submitted'. This indicates that the trial results have been prepared and submitted for posting.
    Difference
    0.1%
    Check dated 2026-08-16T15:38:19.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a new version of the page content. This change is a metadata update and does not modify the study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-09T10:54:41.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor frontend update to the study details page.
    Difference
    0.1%
    Check dated 2026-07-25T18:03:02.000Z thumbnail image

Stay in the know with updates to ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 plus Everolimus in ER+, HER2- Breast Cancer Clinical Trial page.